LY86 and Insulin resistance: MD-1 is a key regulator of heart failure, ischemia-reperfusion, chronic inflammation in adipose tissue, obesity, and insulin resistance, and MD-1 may be a candidate modifier gene for a variety of inflammatory and atopic diseases11.